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Abstract: The paper aims to revive the interest in bioimpedance analysis for pain studies in
communicating and non-communicating (anesthetized) individuals for monitoring purpose. The plea
for exploitation of full potential offered by the complex (bio)impedance measurement is emphasized
through theoretical and experimental analysis. A non-invasive, low-cost reliable sensor to measure
skin impedance is designed with off-the-shelf components. This is a second generation prototype for
pain detection, quantification, and modeling, with the objective to be used in fully anesthetized
patients undergoing surgery. The 2D and 3D time–frequency, multi-frequency evaluation of
impedance data is based on broadly available signal processing tools. Furthermore, fractional-order
impedance models are implied to provide an indication of change in tissue dynamics correlated
with absence/presence of nociceptor stimulation. The unique features of the proposed sensor
enhancements are described and illustrated here based on mechanical and thermal tests and further
reinforced with previous studies from our first generation prototype.
Keywords: noninvasive pain sensor; electrical impedance spectroscopy; time–frequency analysis;
model identification; fractional-order impedance model; nociceptive stimulation
1. Introduction
Human bioimpedance allows for the characterization of pain pathway by providing an electrical
signature, whose time and frequency modulation informs on physiological and electrochemical
phenomena. Beside healthcare assessment systems, skin impedance has been studied in multiple
medical applications as an indicator for the functioning of the human body [1]. There is a wide
spectrum of its utilization for cancer analysis [2], changes in the physiological state, virus detection [3],
or sensation of fear [4]. Nowadays, bioimpedance is increasingly used to estimate the body
composition [5,6] and to interpret the histological composition of different tissues [7].
Electrode recordings of sympathetic activity in skin nerves have been correlated with blood
pressure and electrodermal activity (EDA) even from early times. EDA has a long history in
psycho-physiological research, when observations showed a connection between skin electrical activity
and mental stress, sweat glands, or pain [8]. Despite the common acceptation of its significance,
the researchers’ interest for EDA in pathophysiological applications was revived recently [9].
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Investigation of EDA measurements has been increasingly used for quantitative assessment of
nociception, as pain monitoring remains a well-known problem in clinical management [10].
Nearly 20% of patients still experience severe postoperative pain and approximately 10% have
chronic post-surgical pain [11], while intraoperative awareness continues to occur with reported
pain perception [12].
This paper aims to raise awareness in exploring the full potential of using bioimpedance
spectroscopy for the monitoring of pain. Nowadays, several such devices are available,
including electrodermal response analysis through variability in electrophysical properties [13] and
multivariate signal analysis [14] in time domain. An overview of commercialized nociception monitors
is depicted in [15]. However, the existing reported evidence on the pain monitors from the clinical
trials remains insufficient for their broad applicability and inconclusive [15–17]. Besides, inadequate or
subjective pain assessment can cause complications, so costly errors can be minimized and patient
safety maximized by using a pain monitor. Another reason for such a monitor is the economic burden
of pain management that requires sensing solutions for pain in an objective and non-invasive manner.
The paper presents an analysis of the relationship between pain and dermal impedance with
an in-house developed prototype adequately approved for clinical testing. Mainly, the development
and performance-analysis of Anspec-PRO sensing device—second generation—are addressed.
Anspec-PRO differentiates from the commercial devices in exploring the full potential of bioimpedance
data: 2D to 3D time–frequency analysis. The novelty of this approach consists in using a
multi-frequency excitation signal for pain detection, instead of a fixed frequency value which delivers
a single point of analysis in time–frequency domain; hence, we obtain a surface or spectrogram,
broader in information for a full characterization of the biological tissue response. Using the
image-based results, the application of artificial intelligence algorithms can further contribute in
predicting the pain response. Moreover, the possibility to explore skin excitation by different
self-customized signals and protocols adds value in research. Based on the availability of the input
and output signals, a transfer function can be provided for mathematical modeling. This additional
original element was shown by the development of the parametric nociceptor model [18].
The prototype Anspec-PRO was validated on awake healthy volunteers (part of the development
team) undergoing induced pain, with successful results in detecting and characterizing perception of
pain [19]. Beside tests within controlled laboratory environments, the second generation device was
clinically validated by means of a comparison with a reference commercial device, both methodologies
based on electrodermal activity identification. The observational study in awake postoperative patients
concluded that Anspec-PRO performs equally well as the commercial device under similar conditions,
representing proof of concept for the prototype device [20]. Moreover, Anspec-PRO is currently under
tests in a clinical trial on anesthetized patients for its validation in surgery context, in comparison
to other two commercial pain monitors. The aim of the trial is also to develop an innovative
pharmacodynamic model that can directly link the effects of opioid to an objective pain index.
Here, the detailed hardware and software components of Anspec-PRO along with a signal
analysis are given as follows. Section 2 highlights the methodologies for bioimpedance data analysis
and multisine design. Next, the device is tested in various conditions and the results discussed.
The Discussion Section 4 summarizes the main advantages of time–frequency bioimpedance for pain
evaluation and underlines the versatility of Anspec-PRO device. The paper ends with conclusions and
future perspectives.
2. Materials and Methods
2.1. Background
The last decade reported various efforts in updating and increasing performance of bioimpedance
spectroscopy analyzers, with multi-disciplinary expertise from medical, biological, and engineering
areas. As accuracy increases, the complexity of these non-commercial devices tends to increase as
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well [21,22]. However, the medical practitioner prefers user-friendly devices [23]. The disadvantage
of the end-user devices is that they are relatively expensive, non-transparent, and often limited in
versatility. The medical practitioner needs to make a decision in selection of analgesia devices from
a myriad of methodologies. Consequently, many engineering tools tend to miss the transfer to the
medical research labs as they are too complex to be understood.
Bioimpedance is expressed as a complex number, which is frequency- as well as time-dependent
Z(ω, t) ∈ C [24]. It is a dependent variable that is described by the angular frequency ω (rad/s) and
time t (s). Explored at its full potential, it allows monitoring changes in both time and frequency
domain. By using electrical analogy for skin impedance, it is defined as the ratio of voltage over
current in frequency domain.
In other commercially-available devices, the variability of the phase shift as a function of frequency
is neglected. Hence, the potential of data gathering at no extra cost is not explored. For instance,
BodystatTMMultiscan 5000 and ImpedimedTML-Dex U400 use a fixed frequency range as these are
focused on a single application step. The MedStormTMPainSensor uses the information of a single
frequency that is fixed and evaluates time-domain variability of the conductance (i.e., the real part
of admittance). Most of these devices do not allow exporting the raw data for further analysis and
often output surrogate variable parameters (e.g., L-Dex value, PainMonitor Index, etc.). No claims can
be made on the identification accuracy, making it difficult (if not impossible) to adequately compare
these tools. These commercial devices perform well in specific case for clinical monitoring, but not for
research purposes.
This paper provides a second generation prototype that can be tested with different protocols
or self-designed excitation signals, allowing a complex analysis and modeling of skin biological
phenomena. The tested hypothesis is that skin frequency response provides a detection mechanism
and enables modeling of nociception process (i.e., that is dynamic). This rationale is justified by the
fact that molecular levels are excited, hence generating the action potential which is in charge with
autonomic response and ionic diffusion. The second generation device developed in our laboratory,
which has already received approval to be used in clinical trials as a medical device, is depicted
together with the measurement set-up in Figure 1. Three electrodes are placed on the palmar skin:
two current-carrying (white and red) and one pick-up electrode that measures only the voltage (black);
hence, no polarization occurs. The hardware and software specifications, as well as the user interface
for measurements settings, are detailed in Appendices B–D for both device generations.
Figure 1. The second generation ANSPEC-PRO prototype and related set-up for non-invasive
measurement of skin impedance.
2.2. Multisine Data-Analysis
Following impedance modeling analogy from prior work [25,26], the electrical analogy is made
as in Figure 2. The following variables are defined: U(s) is the off-line designed input/excitatory
multisine signal, ZD(s) is the impedance of the device itself (known), Zs(s) is the skin impedance
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(unknown), N(s) is the unknown secondary input as nociceptor stimulus, V(s) is the actual voltage
over the skin impedance, and I(s) is the current running through the skin. As observed, the system has
two inputs: the known multisine excitation signal U(s) and the unknown nociceptor stimulus N(s).
The measured voltage and current signals, V(s) and I(s), respectively, are the outputs. The variable s






Figure 2. Electrical analogy scheme for skin impedance with nociception stimuli.
The analysis transforms the two time vectors to an impedance in frequency domain using the
classical periodogram method by replacing s −→ jω, with j =
√
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For identification of Ẑs(jω), the nociceptor signal acts as a disturbance. By designing the input
signal U(s) such that it is uncorrelated with the nociceptor stimulus (SUN ≡ 0), (8) holds.
2.3. Multisine Design
To excite multiple frequencies at the same time, a superposition of sines with different frequencies
can be used: a multisine. An advantage of this excitation signal is that one can measure a broad
frequency band in a relatively short time-frame, which is useful in fast time-varying systems.





Ai sin(2π fit + φi) (9)
with frequency fi = f0 +
fl− f0
l i (i = 0, 1 . . . l) and φi ∈ [0, 2π] uniformly distributed pseudo-random
number, giving the sine a random phase shift. Because of the random character of the phase shifts,
the crest factor is not optimized. The crest factor indicates the compactness of the signal and is given as
upeak/uRMS, with upeak the peak value of the signal and uRMS the Root Mean Square of the signal in the
frequency band of interest. A lower crest factor means that more power is injected into the system [27].
For the experiments presented in this paper, an off-line odd multisine is designed, as detailed
in [27], with number of samples N = 300. To avoid spectral leakage, the measurement time is an
integer number times the period of the multisine signal. The length of one period is Ms = 0.02 s,
resulting in a sampling frequency fs = 15 kHz. The input signal provides a persistent excitation for
identification of the skin impedance within the [ f0; fl ] = [100; 1500] Hz frequency interval and has
29 frequency points within these boundary values, linearly distributed in steps of 50 Hz.
Frequency response function (FRF) of a dynamical system is a measure of the modulus and phase
of the output signal as a function of an input frequency, relative to the input signal applied to the
system. FRF provides approximate models for the unknown process. To appropriately characterize the
process dynamics in a given frequency interval, the gathered information must cover the modulus
(in dB) and the phase (in radians or in degrees), or, equivalently, the complex impedance in real and
imaginary parts as a function of frequency (in rad/s or in Hz). Classical methods for estimating FRF are
based on input and output data followed by Fast Fourier Transform (FFT). To estimate the dynamical
frequency response over the frequency range, the process needs to be excited with input signals of the
desired frequencies. Therefore, Anspec-PRO is used for skin excitation over the frequencies specific for
the response of tissue molecules involved in the nociception process.
From the electrodermal activity viewpoint, the activity of the skin layer where the sweat glands
are located (i.e., the stratum corneum) is typically dominated by measurements at low frequencies
(below 1 kHz), while viable skin dominates at higher frequencies (above 100 kHz) [24]. On the
other side, of interest are also the nociceptors activity and action potentials that are triggered by
the painful stimulus, so the whole skin is of interest, from epidermis to deeper layers of dermis.
The free sensory nerve endings can be traced deeper into the epidermal layer or into dermis [28],
and, because measurement depth is strongly dependent on excited frequency range, measurements
done at higher frequencies will capture a bigger skin volume [24].
From the electrical permittivity viewpoint, there are described three different dispersion regions
for biological materials, as follows: α, 10 Hz–10 kHz, for counter-ion effects, active cell membrane
effects, gated channels, ionic diffusion (extracellular fluid level), etc.; β, 1 kHz–100 MHz, for dielectric
property measurement of the cell membrane, passive cell membrane capacitance, etc.; and γ, >10 MHz,
for content measurement of the biological species (intracellular fluid level), etc. [24,29,30]. Since pain
is an electrical signal transmitted by dynamics of potassium channels signaling among intra- and
extracellular fluid, it seems natural to choose the lowest frequency dispersion for exciting the skin
with our device. Concluding, while the stratum corneum with sweat gland activity has been shown to
display a very broad α dispersion, viable skin has electrical properties that display separate α and β
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dispersions [24]. Nevertheless, these different dispersions make the electrical properties converge as
the frequency is increased.
However, the frequencies depend on the applicability of the bioimpedance analyzer, so may
differ for skin moisture or ischemia level [31], specific cells detection [32,33], muscles assessment [34],
and human body condition analysis [35–37]. In short, the different frequencies at which these devices
excite the skin are summarized in Appendix A. Usually, bioimpedance measurements for electrodermal
activity is done by each device over a wide range of frequencies up to 1 MHz, typically at 50 kHz [1,38].
Following this, the present work applies the existing know how of devices for impedance spectroscopy,
but customized for pain measurement. The results included in this paper show the capability of
Anspec-PRO to detect pain through skin measurements for the indicated frequency range.
To conclude, unlike commercial devices, Anspec-PRO is not limited to application of a single
sinusoidal signal and it is versatile to user-defined multisine design.
3. Results of Experimental Validation
3.1. Known Impedance Values
To validate the accuracy of the Anspec-PRO device, a known probe electric circuit is measured.
The multisine, as discussed in the previous section, with an amplitude of 5 V is used as input signal.
For this analysis, a measurement time of 60 s was chosen. The probe circuit consists of a series
connection of a resistor R2 = 12 kΩ and capacitance C1 = 15 nF with a parallel resistor R1 = 10 kΩ.
This circuit has the following transfer function model:
ZRC(s) =
1.84s + 9968
3.386 · 10−4s + 1 (10)
Ten consecutive measurements are performed on this sample circuit with the statistical analysis
depicted in Figures 3 and 4. For the magnitude, the %MSRE is 0.4% and for the phase the %MSRE is
7.2%. An accurate magnitude is obtained, whereas the error for the phase shows to be larger. The low
variability for consecutive experiments (standard error of 1.3946 Ω and 0.1331◦ for the modulus and




































Figure 3. Bode plot of a measured and modeled RC test circuit.
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Figure 4. Boxplot analysis of the set of measurements performed to validate the accuracy of the
developed device.
The obtained results suggest the device is reliable and has a good accuracy and resolution for
the chosen frequency interval. It should be noticed that the circuit is not designed to evaluate any
impedance circuits: large phase shifts can lead to instability in the Voltage Buffer circuit. Following this,
the Op-Amp is not able to drive the load and the results are inconsistent. For our bioimpedance
spectrum analysis applications, the phase shift never reaches the unstable region.
3.2. First Hand Results
The location of the electrodes is decided for the palmar skin, because increased sweat gland activity,
as well as generation of action potentials elicited by nociceptor membrane activation, reveal specific
reactivity to psychological stimulation at palmar sites due to the greater density on these areas.
However, electrode placement is a generic problem and is discussed as a function of the application
area [39]. As to the accuracy of the impedance values between the absence and presence of pain
stimulus, sensors location should be fixed during the protocol and during clinical trials when compared
among cohort groups.
As a proof of concept experiment, the claim is that changes occur in skin impedance during
stimulation, i.e., when perceived as pain in one awake healthy volunteer. This was investigated on one
of the manufacturers, age 35, height 171 cm, weight 83 kg, female, measured for five time intervals.
An input multisine provides a persistent excitation to the skin within the frequency range of 10–77 Hz,
while alternating absence and presence of stimulation generated by mechanical pressure on the finger.
The protocol is as follows:
• Minutes 1–5: The subject is in the nominal state, without applying any pain stimulation (NP1).
• Minute 6: Mechanical pain stimulation is applied by gripping the subject’s finger. The pain test is
known as pressure test (P1).
• Minutes 7–9: The pain stimulation is ceased (NP2).
• Minutes 10–11: Mechanical pain stimulation is continuously applied as earlier (P2).
• Minutes 12–15: The pain stimulation is ceased (NP3).
To show the reliability of the device, the measured impedance for one subject is given in Figure 5
for all measured intervals. From the Bode plot of the normalized complex impedance, it can be seen
that the investigated hypothesis is validated, where the magnitude corresponding to pain intervals
(i.e., P1 and P2) differentiates from absence of pain (i.e., NP1, NP2, and NP3). Additionally, the phase
constancy is presented for all intervals. The rationale is based on the transmission in signaling
Sensors 2020, 20, 6765 8 of 27
pathways that occurs via neuronal activity, namely a framework of cascaded processes, which can
be simplified to that of a ladder network. A constant-phase has already been revealed for neural
populations, modeled as resistance-inductance equivalent electrical network recurrent elements with
such collective behavior [40]. We can speculate that the constant phase for the pain intervals has an
average of −10◦, which suggests a fractional order 0.1, while the magnitude possibly has 2 dB for
decade, as the slope seems to be 0 (i.e., magnitude has a constant of about 0.2 dB).
Figure 5. The Bode plot of the measured impedance for one volunteer during pressure test (NP denotes
no pain and P denotes pain).
From the analysis of variances presented in Figure 6, the mean for pain intervals (P) is statistically
different from no pain intervals (NP), with p-value <0.5. The mean of impedance values for each
excited frequency differs significantly between NP1, P1, NP2, P2, and NP3, respectively.
Figure 6. Statistical analysis of the measured bioimpedance for one volunteer during pressure test.
3.3. 3D Representation of Impedance
Time–frequency analysis tests the hypothesis that the skin impedance is a dynamic system, where
its dynamic properties are caused by the noxious stimulation. To characterize this black-box-like
process, the need of a mathematical model is obvious. The theory of system engineering regarding
identification states that a continuous excitation at system’s specific frequencies is needed [27]. In this
way, we are able to extract a transfer function of the process, which describes the dynamics taking
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place. While a transfer function cannot be estimated in a single frequency point, Anspec-PRO sends a
multisine signal composed of sum of sinusoids in a band-limited frequency interval.
A multisine with amplitude 5 V is used, giving the impedance Z(ω) for 29 frequencies in the
[100, 1500] Hz calculated protocol interval. In biological systems, the acquired signals may have
components from the high-frequent noise of the same order of magnitude. In our case, the complex
impedance topology of the skin tissue is reproducible without the design of complex filtering.
The response to a mechanical pressure induced pain is analyzed, using the protocol proposed in
Section 3.2. The 3D representation of the absolute value of impedance is depicted in Figure 7a for one
subject. The result indicates different impedance values for the moments of pain applied versus the
baseline (first no pain interval). However, when the application of pain has stopped, the small increase
in the impedance values can show the pain memory of the tissue, followed by a lower threshold for
the second interval of pain application. The surface generated by the analysis of the impedance in
function of frequency and time illustrates the change in frequencies. The same trend is depicted in
Figure 7b, where the normalized values of impedance for NP2 are localized in between P1 and P2
as well as NP1 and NP3 on the polar plot. Finally, this result suggests that Anspec-PRO can detect
changes in impedance in the presence and absence of pain, while in-depth specific frequency analysis
is required.
(a) 3D surface (b) polarplot
Figure 7. Impedance representations for one volunteer (NP denotes no pain and P denotes pain).
3.4. Repeatability and Impedance Dependence
To investigate the device repeatability, another protocol is performed in this work for impedance
analysis, but using thermal pain stimulus this time. The multisine (i.e., in the specific frequency range),
the location of the electrodes (i.e., palmar skin) and the data analysis for obtaining complex impedance
are the same as mentioned in Section 3.3 for the mechanical-induced pain protocol.
Thirteen different volunteers (i.e., from the development team) are measured for 14 min while
immersing one of their hand in a recipient with ice-cold water at 10 ◦C in an alternating manner
(see Figure 8. The biometric data of the subjects included in the study are presented in Table 1.
The timeline of the protocol is as follows:
• Minutes 1–2: The subject is in the nominal state, without applying any pain stimulation (NP1).
• Minutes 3–5: Thermal pain stimulation is produced by hand immersion in cold water (P1, P2, and P3).
• Minutes 6–8: The pain stimulation is ceased (NP2).
• Minutes 9–11: Thermal pain stimulation is continuously produced as earlier (P4, P5, and P6).
• Minutes 12–14: The pain stimulation is ceased (NP3).
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Figure 8. The set-up for the thermal protocol using hand immersion in iced-cold water at 10 ◦C.
Table 1. Biometric characteristics data for the subjects included in this study (BMI = Body Mass Index).
# Volunteer 1 2 3 4 5 6 7 8 9 10 11 12 13
Gender M F F M F M M F F M M M M
Age (Year) 24 22 40 24 24 22 24 27 27 25 33 23 23
Weight (kg) 57 110 102 55 53 65 67 71 68 63 65 70 76
Height (cm) 164 160 174 160 165 170 173 180 178 180 165 175 196
Fat (%) 14.75 51.22 44.22 15.10 23.48 15.84 16.18 27.1 26.56 20.04 19.44 16.51 12.83
BMI 21.19 42.96 33.69 21.48 19.46 22.49 22.38 21.91 21.46 19.44 23.87 22.85 19.78
The absolute values obtained for the impedance are in the same magnitude as for the
mechanical-induced pain protocol, but on different volunteers. As observed in Figure 9, there is a linear
dependence between the normalized values of the absolute impedance and height (with correlation
coefficients r = 0.68 and r = 0.71). The results are in agreement with what was expected, as the
impedance value is related to the tissue volume of a conductor to which the one current-carrying
electrode is connected. Consequently, the overall body height of the participant is highly influencing
the impedance measurements.
Figure 9. The normalized impedance against height for 13 volunteers.
The results of multiple comparison tests and of one-way analysis of variance between volunteers
are depicted in Figure 10. The performed statistical analysis in Figure 10a identifies a significant
variation between volunteers for the impedance measurements. For the impedance values scaled
to the BMI of each volunteer, Figure 10b shows six volunteers (red) significantly different from the
comparison group, i.e., Volunteer 1 (blue) and the similar volunteers from the same group (grey).
Looking into the multiple comparison between the intervals with pain and no pain stimulus from the
thermal protocol, Figure 11a illustrates two intervals significantly different from the others: P2 and P3.
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This behavior can be explained by the fact the P1 is the first pain interval that still makes the transition
between the state of no pain and the stimulation caused by the cold temperature during P2 and P3.
For the second period of stimulation (P4–P6), adaptation and numbness occur. Once scaled to BMI,
the impedance means show no difference between the intervals in Figure 11b.
(a) Boxplot for impedance (b) Multiple comparison of impedance scaled to BMI
Figure 10. Statistical analysis of measured bioimpedance for all volunteers during thermal test.
(a) Impedance scaled to baseline (NP1) (b) Impedance scaled to BMI
Figure 11. Multiple comparison tests of measured bioimpedance for all intervals during thermal test.
3.5. Spectrogram Representation
The spectrogram representation of the impedance that exhibits the frequency range delivered by
Anspec-PRO is further proposed. The time–frequency display may be beneficial in providing useful
characteristics of the pain process transfer function. Using short-time Fourier transform, the one-sided
modified periodogram estimate of the PSD (power spectral density) or power spectrum of each
segment is computed. The spectrogram for one volunteer tested with the thermal protocol, described in
Section 3.4, is depicted in Figure 12. For every minute, it displays the spectrum of impedance signal
around the excited frequency of 100 Hz in which the power/frequency (dB/Hz) over time is color
coded. Starting from the moment of applying pain, the power of bioimpedance is decreasing compared
with the baseline moment of no pain (i.e., Minute 2). However, similar behavior is expressed during
intermediary minutes of pain absence (i.e., Minutes 6 and 7). Here, the physiological effect that occurs
is pain memory, already found in other studies using Anspec-PRO [18,19]. The second interval of
induced thermal-pain (i.e., Minute 9) starts once again with visible differences from the last minute of
no pain (i.e., Minute 8). The results show different spectrograms of the impedance for pain and no
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pain minutes, concluding that in-depth analysis of the acquired power spectrum will be able to classify
these moments.
Figure 12. 3D representation (spectrogram) of impedance signal for one volunteer measured during
the thermal pain protocol (NP denotes no pain and P denotes pain).
Here, we show the utility of the simple time–frequency representation—the spectrogram—in
giving probably a more comprehensive yet still intuitive means of visualizing the electrical human
response to painful stimulus. However, in-depth analysis on visualization and window properties that
affect the spectrogram appearance, as well as more measurements, need to be tackled in the future
work. However, this analysis is not the subject of the current paper.
3.6. Bioimpedance Modeling
Following the experimental studies, bioimpedance modeling is implied, where fractional-order
values are appropriate for model identification (because of the constant phase and slope of the
magnitude) [41]. Then, the behavioral derived electrical equivalent circuit model of the skin allows
connecting the impedance measurements to the physiological processes. Using an appropriate circuit
model to fit the experimental data, the obtaining parameters’ values are further analyzed for the
pain–no pain situations. Recent works also discuss fractional-order circuits in various forms [42–45].
Originating our prior work on modeling nociception stimulation with fractional-order impedance
models (FOIM) [46,47], two FOIM models are then adapted and proposed in their electrical analogs in
Figure 13. For the individuals undergoing the thermal tests, the fitting of the proposed models is done
onto intervals with pain stimuli and without.
Therefore, the electrical impedance of the electrochemistry skin impedance shunt model presented
in Figure 13a is expressed from the frequency response in the complex variable s = σ ∗ jω, as follows:
ZFOIM(s) =
1










Sensors 2020, 20, 6765 13 of 27
where α is a fractional parameter (0 ≤ α ≤ 1) that defines the frequency behavior of the
bioimpedance dispersion.
(a) Electrochemical skin impedance shunt (b) Simplified FOIM
Figure 13. Structure of fractional impedance models proposed.
Different non-integer order values from the FOIM model (Equation (11)) are then identified for
one subject in Table 2.
Table 2. Parameters obtained from FOIM model (Equation (11)) identification.
Interval R1 LCPE α R2 L C
P1 0.099 0.008 0.430 29.075 0.062 131.7889
NP2 0.155 0.002 0.527 102.276 2904.545 0.0009
The second model proposed is a FOIM model composed of fewer elements, i.e., a resistance (R)
and a constant phase element (CPE) at a fractional order:




with the identified parameters for one subject in Table 3.
Table 3. Parameters obtained from FOIM-CPE model (Equation (12)) identification.
Interval R 1/CCPE α
P1 2.683 × 10−10 23.732 0.279
NP2 5.437 × 10−10 53.857 0.356
To compare the extracted parameters of stimulated and non-stimulated skin tissues,
individual differences can be seen for values characterizing pain (P1) versus no pain intervals (NP2).
However, the statistical analysis of impedance variation between pain (P1) and no pain intervals (P2)
for all the volunteers included in the study did not show a significant difference (p > 0.05). The only
exception is the parameter corresponding to the CPE impedance (1/C) from Equation (12), which was
found to be significantly bigger for no pain intervals (p < 0.05). One step further is to look at the














with the ratio γ = GsHs proposed in [47] as a relation to hysteresivity that describes the dynamics of the
tissue in response to sinusoidal behavior. Figure 14 depicts the analysis of variance of γ, resulting in
significant higher hysteresivity met in tissue during painful stimulus. Then, a similar trend is followed
for γ variation obtained from both models.
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(a) γ calculated from FOIM (b) γ calculated from FOIM-CPE
Figure 14. Boxplot of the calculated histeresivity from the frequency response data of all volunteers.
From this identification procedure done on all volunteers, it was observed that a
significant intra-patient variability between pain and no pain characterizing parameters exists.
Nevertheless, the inter-patient variability is too high, so a significant difference between all pain
and no pain intervals from all volunteers cannot be obtained. From here, one can deduce that
Anspec-PRO needs calibration per person, as one population model that can estimate generalized
impedance values is not going to fit everyone. The solution is a personalized adaptive approach,
opposed to the commercial pain monitors that usually give a pain index based on population models.
For only one volunteer, the fitting of the FOIM models from Equations (11) and (12) onto
the frequency response complex impedance data are depicted in Figures 15 and 16, respectively.
The simulations using extracted FOIM parameters are given as blue circles, while data are represented
in red. Both models applied to characterize the skin electrical impedance show a good fit with the
frequency dependent tissue impedance. This further validates that the FOIM model is appropriate to
be used for fitting collected bioimpedance datasets.
(a) Pain interval (P1) (b) No pain interval (NP2)
Figure 15. Identified FOIM model for the frequency response data of one volunteer.
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(a) Pain interval (P1) (b) No pain interval (NP2)
Figure 16. Identified FOIM-CPE model for the frequency response data of the same volunteer.
3.7. Other Features
Both generations of Anspec-PRO device have already been used in several studies and a summary
of the findings is given below.
• To investigate temperature tolerance of volunteers, the following hypotheses were tested on first
Anspec-PRO: (i) the bioimpedance is increasing in time when the volunteer has one of his/her
hands immersed in ice-cold water due to the new environment change and impact with ice-cold
water; and (ii) the impedance of extracellular fluid is dependent on each individual after the
threshold of pain is reached. The outcome of these measurements indicates that the device can
successfully detect thermal pain. More details about this analysis can be found in [19].
• The authors also investigated detection of nociceptor stimulation followed by related tissue
memory effects, using first Anspec-PRO. The method and model indicate that nociceptor
stimulation perceived as pain in awake healthy volunteers is non-invasively detected.
The existence of a memory effect is proven from measured data [18].
• Spectrographic analysis of the skin impedance measured with second Anspec-PRO device was
approached to obtain a wider view towards the signal [20].
• Model identification was performed based on parametric methods. For identification purposes
the multi-frequency voltage and corresponding current signals (multisine input–output) are used.
More details about it can be found in [48].
4. Discussion
Pain is a subjective sensation with biological origins that depends strongly on the type of
nociception phenomena [49]. Different from pain as a feeling, nociception denotes the complex
sensory process that provides signals for pain triggering [50]. To this extent, characteristic pain
indicators can be found in both mental stress effects (e.g., emotional sweating) and nerve endings
transduction and transmission (e.g., nociceptors). As electrodermal phenomena are correlated with
the psychological arousal, the human sweat is commonly measured through the skin conductance
level or the responses originated from the activation of the sympathetic nervous system [8,51].
Moreover, when the nociception is initiated, the peripheral nociceptors fire, generating action potentials.
They represent the depolarization of nociceptors (i.e., neuronal membranes), which can result from
released substances and ion-gated channels activation by different stimuli [50]. This trans-membrane
potential is dependent on the concentration gradients of ions across the membrane that determines
different electrophysical properties and can be sensed through bioimpedance.
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This paper underlines the important feature of the newly developed prototype Anspec-PRO,
namely the possibility to describe the complex impedance in both time- and frequency-related
characteristics. The benefit introduced by this sensor is the volume of data collected and the access
to different post-processing methods available. Due to the customizable input signal, the desirable
optimal extraction of dynamic process information is possible, with the aim of model identification of
the excited process. Unlike commercial pain monitors, the promising results presented in this paper on
FOIM identification show the opportunity of going in the research direction of personalized medicine,
specifically obtaining a pain descriptor calibrated per each patient, and not based on population
models. Further in-depth time–frequency analysis of the skin impedance to be correlated to pain
levels is required for clinical relevance, using the proposed Anspec-PRO for acquiring individualized
complex information.
It is shown that fractional-order impedance models are natural solutions to pain pathway [18].
This paper presents results on the ability of two proposed fractional-order models to catch the variations
of the impedance measured during painful excitation and in absence of it. Modeling such phenomena
in terms of ordinary differential equations of integer order typically leads to unwieldy sets of equations
that appear contrived. On the other hand, differential equations of fractional order tend to naturally
capture intrinsic phenomena in complex dynamical systems [52,53]. Their lumped equivalent models
are parsimonious representations with few free parameters and have a seemingly natural ability to
mimic nature [54–56].
The added value of our prototype over other pain sensors consists on allowing to send
a range of frequencies to excite the system for pain level evaluation in patients undergoing
anesthesia or ICU recovery. For the Anspec-PRO device, the frequency range for skin excitation
proven in this work to successfully capture pain induced changes in bioimpedance is [10; 1500] Hz.
Comparatively, other future research users have the possibility to personalize the input signal.
While the impedance data as well as the methodology developed in this work have proven the
tested hypothesis in terms of nociception detection and modeling, a limitation of this study is that the
obtained impedance values are yet to be integrated in a personalized index for pain. Perhaps, the small
number of subjects included in the self-experimental evaluation can be considered also a limitation.
In addition, one could evaluate the nerve endings from the epidermis and dermis layers of skin
that respond to painful stimulation; nevertheless, such an invasive method is not directly useful in
our endeavor.
The already available results indicate that the developed prototype is able to capture the signaling
pathways and deliver an objective measure for pain. A clinical trial was conducted in patients
recovering from anesthesia, and the results show a good performance for the prototype to identify
changes in pain pathways by measuring the skin impedance [20]. As the aim of this paper is to
illustrate the development methodology of our prototype, the existing prior results with more details
about the previous work can be found in Section 3.7.
5. Conclusions and Perspectives
This paper describes the development and validation of a bioimpedance sensor for time–frequency
analysis of pain phenomena. The Anspec-PRO device uses off-the-shelf accessible tools and signal
processing algorithms explored at their full potential. The device is non-invasive and portable in its
design, while versatile to user-defined testing conditions. The device offers access to raw data for
post-processing analysis and is easily adjusted to the design of an experiment (e.g., different protocols
and different simulations for pain). The input signal can be altered by the user without the need for
additional hardware, which avoids high experimental costs.
As for the next steps, an individualized index of pain level from Anspec-PRO is envisaged
for use in monitoring communicative and anesthetized patients. One other phase is the in-depth
spectrographic analysis, by using deep learning algorithms for extracting the optimal features that
correlate best with the NRS given by the patient (for awake patients) or with BIS (for anesthetized
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patients). Along with the post-processing, the prototype Anspec-PRO is currently involved in
a randomized controlled trial for intraoperative nociception monitoring during total intravenous
anesthesia in University Hospital Ghent, Belgium, approved by the Ethics Committee (BC-08020) and
by the Federal Agency for Medicines and Health Products Brussels (FAGG/80M0840).
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FFT Fast Fourier Transform
FRF Frequency Response Function
FPGA Field-Programmable Gate Array
GUI Graphical User Interface
MSRE Mean Square Root Error
Op Amp Operational Amplifier
PSD Power Spectra Density
RC Circuit with both a resistor (R) and a capacitor (C)
RE Reference Electrode






Appendix A. Frequency Ranges
Different purposes for impedance measurements have decided the frequency range of tissue
excitation for each application, as depicted in Table A1.
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Table A1. Frequencies used for impedance measurements.
Level Frequency Range Reference
Cells 100 Hz to 1 MHz [32]10–1 to 105 Hz [33]
Skin
30 Hz–10 MHz [57]
20, 60, 100, 140, 180, 220 Hz [58]
5 kHz to 1 MHz [59]
10 Hz to 100 kHz [60]
Muscle 0.02, 25.02, 50.02, 1000.02, 3000.02, and 5000.02 kHz [57]
Entire body 10 Hz, 1 kHz, 100 kHz, 10 MHz, 1 GHz, and 100 GHz [35]
Bioelectrical impedance analysis
5 to 1000 kHz [36]
100 Hz to 100 kHz [37]
4–1000 Hz [61]
32 to 992 kHz [62]
30 Hz–10 MHz [57]
Appendix B. Hardware Components
The prototype Anspec-PRO was firstly designed in a wooden box for tests in our laboratory [18,19],
as the first generation is depicted in Figure A1a. For use in clinical trials [20], a second generation was
developed, displayed in Figure A1b.
The hardware architecture consists of several parts that are illustrated in Figure A1:
1. the data-acquisition unit (1) National Instruments’TM compactRIO connected to its power supply
(3); and
2. the signal conditioning circuit (2), also connected to its power supply (4).
A laptop is used to capture, save, and display measured data. An Ethernet cable (A) provides
the communication between the device and the laptop, over a local network. The device is connected
to the electrodes cable (B) and to the power cable (C). The electrodes and electrode connectors are
CE-marked (according to MDD93/42/EEC).
(a) (b)
Figure A1. Proposed in-house prototype and equipment for bioimpedance measurements:
Anspec-PRO. Two generations are presented: (a) the first generation (wooden box) ((1) cRIO; (2) signal
conditioning circuit; (3) power supply of cRIO; (4) power supply for (2); (5) on/off-switch; (A) Ethernet
cable; (B) electrode connector; and (C) power cable); and (b) the second generation with the optimized
design for use in clinical trials that contains the same components as the first version.
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The prototype follows a modular design scheme (see Figure A1a):
• Data-acquisition is done with the embedded controller CompactRIO-9074 (cRIO) from National
Instruments (Austin, Texas), which has a Field-Programmable Gate Array (FPGA) chip (Xilinx’
FPGA Spartan-3 1M), particularly useful for setups where a minimal robustness must be ensured
for sending and acquiring signals in real-time. The FPGA is programmed within LabVIEW
software. The National Instruments PS-15 Power Supply is used to power two C-series I/O
modules:
– Analog-to-Digital (ADC) converter as Analog Input (NI-9201): voltage input signals are
scanned, buffered, conditioned, and then sampled by a single ADC.
– Digital-to-Analog (DAC) converter as Analog Output (NI-9263): each channel of the Analog
Output module has a DAC that produces a voltage signal.
These are stand-alone data acquisition units and are used for converting the physical signal
(analog) into a sequence of bits (digital signal) or vice versa.
• Signal conditioning circuit is an interface between the computer and the electrodes,
mitigating unwanted effects, such as noise or AC coupling. The signals coming from and going to
National Instruments’ cRIO need to be conditioned before reaching the skin. This is done with
a circuit containing operational amplifiers, which are connected to a DC power source with the
voltage limited to ±10 V. The circuit encompasses:
– Operational Amplifiers’ voltage source, in-house created for acquiring at least a +10 VDC and
−10 VDC output compared to a common ground, as required by the I/O module manuals.
An artificial Ground (GND) is created by the means of a galvanic separator, a transformer.
However, to achieve the wanted supply voltages, a low drop-out voltage regulator is used to
stabilize the output voltages. A rail with a positive voltage (MC7812) and with a negative
voltage (MC7912), compared to this GND, are supplied to the voltage regulators, with the
output voltage ±12 V.
– Voltage Buffer (VB), which assures a correct voltage at the output of the circuit, being used
just for transferring the voltage from the circuit to the skin. The active component is an
Operational Amplifier (Op Amp) (Texas InstrumentsTM MC1458P). In a classic voltage buffer
design, the output of the Op Amp is connected to the inverting supply, to achieve negative
feedback. However, in this case, the voltage signal is first sent through a filter, namely the
skin. The output signal is limited to ±15 V and ±25 mA.
– TransImpedance Amplifier (TIA) circuit consists of an Op Amp (Analog DevicesTM ADA4077),
which, together with a resistor-capacitor circuit, allow transforming the current into a
voltage. This process is motivated by the fact that ADC AI connected to cRIO can acquire
only voltages, but current is also required for impedance calculations. However, by placing a
resistance in the network, the current can be calculated from the measured voltage, based on
Ohm’s law (v = R× i).
Device components are listed in Table A2, followed by specifications detailed in Table A3.
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Table A2. Electrical components of the following modules: (cRIO) NI-compactRIO; (S) Op Amp voltage
source; (VB) Voltage Buffer; and (TIA) Transimpedance Amplifier.
Module Component Manufacturer Nr
cRIO cRIO-9074 National Instruments 1
cRIO NI-9201 National Instruments 1
cRIO NI-9263 National Instruments 1
cRIO PS-125 National Instruments 1
cRIO Ethernet cable (5E - patched) / 2
S PCB EELAB 1
S 2way PCB Terminal Block Phoenix 1
S Transformer 15 V Block 1
S Diodes −400 V ON Semiconductor 6
S Electrolytic Capacitor (3300 nF–35 V) United Chemi-Con 2
S Voltage Regulator (+12 V/1 A) (MC7812) ON Semiconductor 1
S Voltage Regulator (−12 V/1 A) (MC7912) ON Semiconductor 1
S Electrolytic Capacitor (100 µF–25 V) Nichicon 2
S Film Capacitor (0.1 µF–63 V PET) Kemet 2
S Heat Sink TO-220 AAVID-Thermalloy 2
S/VB 3way PCB Terminal Block Phoenix 3
VB Op Amp MC1458P Texas Instruments 1
VB 4way PCB Terminal Block Phoenix 1
VB Audio Connector (3 contacts, Jack 3.5) Pro Signal 1
VB Sensor Cable (3 electrodes, Jack 3.5) / 1
VB/TIA PCB Own Design 1
TIA Op Amp ADA4077-2 Analog Devices 1
TIA Resistance (1000 Ω–5%) Velleman 1
TIA Ceramic Capacitor (10 pF–50 V) Kemet 1
Table A3. Key specifications.
Component Electronic Specifications
ADC cRIO NI-9201 Input range: ±10 V; 500 kS/s; ADC resolution: 12-Bit; Measurement
voltage: ±10.3 V; Overvoltage protection ±100 V.
DAC cRIO NI-9263 Output range: ±10 V; 100 kS/s/ch Simultaneous; DAC resolution:
16-Bit; Current drive: ±1 mA per channel maximum; Overvoltage
protection: ±30 V.
NI LabVIEW FPGA Module Loop rate of executable control algorithms up to 300 MHz.
Power Supply NI PS-15 AC 100–120/200–240 V Auto-select input; The output terminals
provide 24–28 VDC with 5 A of current.
TransImpedance Amplifier ADA4077-2 Input Voltage Range: ±15 V; Output voltage range: 14 V; Output
Current: ±10 mA; Gain Bandwidth: 3.6 MHz.
Voltage Buffer MC1458 Input Voltage: ±15 V; Supply voltage: 15 V; Maximum-output-swing
bandwidth (closed loop): 14 kHz; Unity Gain Bandwidth: 1 MHz;
Short-circuit output current: ±25 mA; Supply current (both
amplifiers): 3.4 mA.
The printed circuit board layout is presented in Figure A2 with a magnification of 100%.
The conditioning circuit for a three-electrode measuring technique is designed using a standard
electronics circuit described in [24]. DAC module generates an alternating electric voltage of
known amplitude to be injected into the human body through one electrode, after VB filtering.
Thus, the multisine signal Vvb filtered with the VB configuration is applied on the skin, via the
working electrode (WE). This voltage induces a corresponding current in the circuit related to the
impedance of the human body. The current pathways are from WE to the counter electrode (CE).
This CE is grounded through the TIA, while no current flows into the reference electrode (RE) due
to the high input resistance of Op Amp. All the current i is drawn towards the CE, which closes the
circuit. The impedance Z transforms the current into a voltage that is proportional to the current,
i.e., VTIA(s) = Z(s) · i(s). By means of RE located in the current path, the TIA subsystem measures the
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voltage generated by the circulation of the current. To obtain both the voltage and current signal in
time, VTIA(t), and Vvb(t) are acquired simultaneously. A schematic representation of the interface is
given in Figure A3.






















Figure A3. Block diagram for the signal conditioning circuit with Voltage Buffer (VB) and
TransImpedance Amplifier (TIA). The dotted line represents a simplified representation of the electrical
equivalent network of the skin. The three electrodes are indicated with Counter (CE), Reference (RE),
and Working (WE) electrode.
Ideally, the RE electrode is placed very closely to CE electrode. In [24], a better electrode design is
proposed based on this observation. The electrode consists of three concentric rings. The inner ring
is a circular CE, the middle ring of non-conductive material is used to separate the inner circle from
the outer ring, which consists of a conductive ring of gel to act as the RE. By using the three-electrode
configuration, one achieves a quantification of the impedance underneath the CE. The upper skin layer,
the Stratum Corneum (SC), has a much higher resistivity than the underlying viable skin (VS) layer.
As the skin is a volume conductor, the current will be spread over the volume, bringing into attention
the current density J [A/m3]. However, the current flow can be simplified due to the difference in
resistivity and the fact that current will follow the path with the least resistance. The current will take
the shortest path through the SC towards the less-resistive VS. Next, it will flow until it reaches the CE.
The current will flow to the CE electrode through the SC, again taking the shortest path. Because of
the lower resistivity, the impedance of the SC right underneath the CE will dominate the reading
of impedance.
For safety reasons, the device’s voltage and current are limited to protect the patient/volunteer.
The protection is in accordance with the European Directive for Medical Devices [63].
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Appendix C. Software Architecture
The software architecture is twofold: the host computer software and the target (cRIO) FPGA
software, as given in Figure A4. The LabVIEW software package provided by National Instruments




































Figure A4. Software architecture and data flow indicated by the arrows.
The flowchart for software sequence is detailed next.
1. Before starting a new acquisition, all parameters are initialized and the graphs are cleared in the
host program.
2. The user manually introduces the analysis specific parameters and the path that indicates the
location of the .txt file containing the input/excitatory multisine signal.
3. If the parameters are correctly assigned, the .txt file is read and converted into an array with
double precision numbers.
4. All buffers are initialized and sufficient memory is allocated in order to avoid data overflow.
5. The host sends the parameters and the signal array to FPGA target with the help of a
First-In-First-Out (FIFO) Host to Target—Direct Memory Access (DMA) buffer, called Analog Output
(AO). DMA makes it possible to transfer data from one hardware subsystem to another in real-time.
The data are saved into another buffer AOH1 which is a Target-Scoped Block Memory FIFO buffer,
with the same specifications of AO. Another buffer AOH2 is identical to buffer AOH1, hence both
allow the ping-pong procedure explained below for the AO loop.
6. If the host buffer is emptied and all data are copied on the target, the target software is ready for
starting the data acquisition. The user receives a green-light in the graphical user interface (GUI)
to start the data acquisition from the patient.
7. Once the user starts the data acquisition, on the FPGA software, there are two parallel while loops:
the Analog Output (AO) loop and the Analog Input (AI) loop:
7.1. In the AO loop, the input array Vin enters the Ping-Pong Buffer. The array elements
ping-pong between two buffers, one active and one passive.
7.2. With every sampling period Ts, the active buffer is emptied element-wise and each
value is sent to the output port (DAC module), while also saved in the passive buffer.
When one buffer is filled, they interchange between being active and passive, thus creating
a continuous periodic signal by repeatedly sending to the electrodes the same array of
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numerical values Vin. This particular implementation architecture enables to continuously
iterate through an array on the FPGA chip in delay-free real-time.
7.3. In parallel, the I/O hardware module measures the voltages from electrodes. With reference
to Figure A3, AI modules acquire the voltage (VVB) from WE and the voltage of the output of
TIA (VTIA), after being transformed from the bio-current by the active circuit implemented
in the device.
7.4. The DAC from AI module transforms the analog signals into digital data.
7.5. For every sample from ADC, the two voltages, VVB and VTIA, are stored in the Data Buffer,
which is represented by two FIFO buffers: AIVoltage (for VVB) and AICurrent (for VTIA).
Pipeline method is used to guarantee that acquiring the voltage and writing it to the buffer
is done simultaneously.
7.6. The Data Buffer is emptied in batches through a UTP cable into the Data Receiver, which is a
container for all data on the host software.
8. In parallel, a while loop on the host side starts reading all elements waiting in the Data Buffer
(AIVoltage and AICurrent) into the Data Receiver. The measured voltage VTIA that describes the
current is processed in the host software and the correct equivalent voltage is obtained. The data
undergo a 180◦ phase shift, because the inverting properties of the op–amp, and the numerical
values are divided by the resistance, which is 1000 Ω.
9. The while loop is stopped whenever an error is encountered or when the user presses the
Stop button.
10. The user can save the data in a .xlsx file every Ts on a specific location on the computer.
The parameters VVB and VTIA are plotted in real time in the GUI. The impedance Z(ω, nTs)
is calculated and given in parallel with the data-acquisition and printed in the graphical user
interface (GUI).
Appendix D. User Interface
The host software returns the graphical user interface (GUI) for the measurements and provides
the user for the software initialization and parameters definition, followed by visualization in real time
of the output signals.
Prior to data acquisition, the host software demands several parameters that are unique for
each experiment:
• the input signal Vin;
• FPGA timer parameters;
• buffer allocation parameters; and
• parameters influencing the data analysis.
To initiate a measurement loop, the user sees the interface presented in Figure A5. The following
fields are depicted: (1) file for input signal a priori designed; (2) sampling frequency [Hz]; (3) frequency
resolution [Hz]; (4) maximum amplitude of output signal, in order to control saturation of the input
signal to the patient (seen on 10); (5) default number of seconds that are saved per data file (60 s);
(6) start acquisition button; (7) path for data saving (current and voltage will be recorded in an excel
file); (8) stop acquisition button; (9) save data button; and (10 and 11) figures of the input voltage and
the output current.
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Figure A5. Graphical user interface on the laptop that connects to Anspec-PRO device.
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